Trifecta Capital Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Trifecta Capital Advisors, LLC

  • $452 Billion
  • Q2 2024

A detailed history of Trifecta Capital Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Trifecta Capital Advisors, LLC holds 245 shares of XBI stock, worth $24,894. This represents 0.01% of its overall portfolio holdings.

Number of Shares
245
Previous 245 -0.0%
Holding current value
$24,894
Previous $23.2 Million 2.3%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 17, 2023
BUY
$76.72 - $85.66 $18,796 - $20,986
245 New
245 $20.3 Million

Others Institutions Holding XBI

# of Institutions
894
Shares Held
94.6M
Call Options Held
18.4M
Put Options Held
31.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Trifecta Capital Advisors, LLC Portfolio

Follow Trifecta Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trifecta Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trifecta Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email